loading

Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Interest Income/Expense
2.39%
0.368
0.377 0.373 0.355 0.344
Operating Income/Loss
6.12%
-7.974
-7.514 -6.592 -7.47 -7.581
Nonoperating Income/Loss
169.23%
0.07
0.026 -0.194 -0.111 -0.055
Income/Loss From Continuing Operations Before Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Net Income/Loss
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Diluted Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Basic Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Diluted Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$65.24
price down icon 0.70%
$19.26
price down icon 0.31%
$32.51
price down icon 0.98%
$22.62
price down icon 8.05%
$93.91
price down icon 0.71%
biotechnology ONC
$222.24
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):